Financial Snapshot

Revenue
$295.2M
TTM
Gross Margin
40.36%
TTM
Net Earnings
-$220.3M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
490.57%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$491.1M
Q2 2024
Cash
Q2 2024
P/E
-12.07
Nov 08, 2024 EST
Free Cash Flow
-$74.94M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $245.1M $203.6M $132.3M $90.10M $54.39M $25.43M $10.77M $2.270M
YoY Change 20.41% 53.83% 46.87% 65.67% 113.89% 136.16% 374.32%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $245.1M $203.6M $132.3M $90.10M $54.39M $25.43M $10.77M $2.270M
Cost Of Revenue $155.4M $119.3M $80.62M $61.41M $47.43M $32.19M $24.02M $9.420M
Gross Profit $89.73M $84.24M $51.71M $28.69M $6.959M -$6.762M -$13.25M -$7.150M
Gross Profit Margin 36.61% 41.38% 39.08% 31.85% 12.8% -26.59% -123.09% -314.98%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $189.7M $212.9M $135.9M $103.3M $80.13M $43.45M $26.06M $18.27M
YoY Change -10.9% 56.69% 31.6% 28.88% 84.41% 66.73% 42.64%
% of Gross Profit 211.46% 252.8% 262.8% 359.89% 1151.4%
Research & Development $106.9M $120.3M $69.07M $43.01M $35.68M $20.35M $19.17M $18.23M
YoY Change -11.15% 74.18% 60.61% 20.52% 75.37% 6.15% 5.15%
% of Gross Profit 119.13% 142.82% 133.57% 149.88% 512.76%
Depreciation & Amortization $29.30M $16.50M $9.800M $6.700M $6.100M $5.727M $5.021M $4.230M
YoY Change 77.58% 68.37% 46.27% 9.84% 6.51% 14.06% 18.7%
% of Gross Profit 32.65% 19.59% 18.95% 23.35% 87.66%
Operating Expenses $296.6M $333.3M $205.0M $146.3M $115.8M $63.80M $45.23M $36.51M
YoY Change -10.99% 62.59% 40.13% 26.31% 81.53% 41.05% 23.88%
Operating Profit -$217.2M -$249.0M -$152.7M -$140.1M -$108.9M -$70.56M -$58.48M -$43.66M
YoY Change -12.79% 63.05% 9.03% 28.69% 54.27% 20.65% 33.95%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense $5.000K $2.982M $367.0K $787.0K $1.294M $1.313M $905.0K -$510.0K
YoY Change -99.83% 712.53% -53.37% -39.18% -1.45% 45.08% -277.45%
% of Operating Profit
Other Income/Expense, Net -$667.0K -$1.087M -$1.370M -$182.0K -$265.0K -$121.0K -$55.00K $70.00K
YoY Change -38.64% -20.66% 652.75% -31.32% 119.01% 120.0% -178.57%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$203.5M -$228.3M -$154.0M -$139.5M -$107.4M -$70.99M -$59.03M -$44.09M
YoY Change -10.87% 48.2% 10.38% 29.96% 51.25% 20.27% 33.89%
Income Tax $1.152M -$10.41M -$1.930M $382.0K $292.0K $242.0K $280.0K $0.00
% Of Pretax Income
Net Earnings -$204.6M -$217.9M -$152.1M -$139.9M -$107.7M -$71.24M -$59.31M -$44.09M
YoY Change -6.08% 43.24% 8.69% 29.96% 51.14% 20.11% 34.52%
Net Earnings / Revenue -83.48% -107.02% -114.94% -155.31% -197.98% -280.16% -550.85% -1942.29%
Basic Earnings Per Share -$3.60 -$4.04 -$3.15 -$3.57
Diluted Earnings Per Share -$3.60 -$4.043M -$3.152M -$3.571M -$3.921M -$2.677M -$2.229M -$1.657M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $336.4M $505.0M $477.9M $290.0M $138.1M $80.80M $62.20M $55.90M
YoY Change -33.38% 5.67% 64.78% 109.99% 70.92% 29.9% 11.27%
Cash & Equivalents $286.5M $378.7M $465.8M $93.70M $46.70M $80.80M $31.20M $28.60M
Short-Term Investments $49.90M $126.3M $12.03M $196.3M $91.40M $0.00 $31.00M $27.30M
Other Short-Term Assets $11.70M $11.91M $8.283M $6.200M $2.600M $3.500M $1.500M $1.200M
YoY Change -1.8% 43.84% 33.6% 138.46% -25.71% 133.33% 25.0%
Inventory $32.10M $39.31M $31.80M $12.30M $7.300M $6.000M $1.800M $1.200M
Prepaid Expenses
Receivables $44.10M $40.29M $26.21M $25.40M $10.80M $5.300M $2.200M $700.0K
Other Receivables $0.00 $0.00 $2.337M $1.000M $1.300M $100.0K $100.0K $0.00
Total Short-Term Assets $424.3M $596.5M $546.5M $334.9M $160.1M $95.70M $67.90M $59.00M
YoY Change -28.87% 9.15% 63.18% 109.18% 67.29% 40.94% 15.08%
Property, Plant & Equipment $203.4M $214.4M $105.7M $59.20M $20.80M $12.30M $14.80M $14.60M
YoY Change -5.13% 102.82% 78.55% 184.62% 69.11% -16.89% 1.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.500M $150.5M $9.204M $3.400M $4.400M $5.900M $900.0K $500.0K
YoY Change -94.35% 1535.22% 170.71% -22.73% -25.42% 555.56% 80.0%
Total Long-Term Assets $352.1M $364.9M $155.6M $64.00M $26.90M $20.10M $17.80M $17.50M
YoY Change -3.51% 134.51% 143.13% 137.92% 33.83% 12.92% 1.71%
Total Assets $776.4M $961.4M $702.1M $398.9M $187.0M $115.8M $85.70M $76.50M
YoY Change
Accounts Payable $14.10M $20.09M $14.90M $4.800M $9.800M $7.500M $2.800M $2.300M
YoY Change -29.82% 34.85% 210.42% -51.02% 30.67% 167.86% 21.74%
Accrued Expenses $51.50M $50.83M $36.98M $25.30M $16.40M $7.600M $5.600M $4.600M
YoY Change 1.31% 37.47% 46.15% 54.27% 115.79% 35.71% 21.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.552M $3.300M $3.300M $2.500M $0.00 $1.400M
YoY Change -100.0% -52.97% 0.0% 32.0% -100.0%
Total Short-Term Liabilities $73.30M $90.66M $63.05M $36.00M $30.40M $18.50M $9.500M $8.700M
YoY Change -19.15% 43.79% 75.14% 18.42% 64.32% 94.74% 9.2%
Long-Term Debt $0.00 $0.00 $0.00 $1.400M $4.400M $298.3M $209.4M $144.2M
YoY Change -100.0% -68.18% -98.52% 42.45% 45.21%
Other Long-Term Liabilities $79.60M $81.33M $58.22M $25.20M $200.0K $300.0K $100.0K $200.0K
YoY Change -2.13% 39.68% 131.05% 12500.0% -33.33% 200.0% -50.0%
Total Long-Term Liabilities $79.60M $81.33M $58.22M $26.60M $4.600M $298.6M $209.5M $144.4M
YoY Change -2.13% 39.68% 118.89% 478.26% -98.46% 42.53% 45.08%
Total Liabilities $153.0M $172.0M $121.3M $62.60M $34.90M $317.2M $219.0M $153.1M
YoY Change -11.04% 41.82% 93.73% 79.37% -89.0% 44.84% 43.04%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 56.89M shares 53.89M shares 48.25M shares 39.19M shares
Diluted Shares Outstanding 56.89M shares 53.89M shares 48.25M shares 39.19M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.6598 Billion

About Twist Bioscience Corp

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 919 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The firm leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. The company has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. The company offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. The company offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Industry: Biological Products, (No Diagnostic Substances) Peers: Arcus Biosciences Inc EQRx, Inc. Immunitybio Inc Fate Therapeutics Inc IVERIC bio, Inc. Prometheus Biosciences, Inc. SAGE Therapeutics Inc ProKidney Corp Verve Therapeutics Inc